Scientists at King’s College London have made a groundbreaking discovery regarding the cause of asthma, offering hope for new treatments that could prevent the life-threatening disease. Unlike current treatments that focus on inflammation, the study reveals that many asthma symptoms, including inflammation and mucus secretion, stem from the mechanical constriction of airways during an asthma attack. This constriction leads to the destruction of the airway barrier, exacerbating symptoms and increasing the risk of infection.
By understanding this mechanism, researchers have identified a potential solution using gadolinium, a compound that blocks cell extrusion and prevents airway damage in mice models. This discovery opens new avenues for the development of treatments that target the underlying cause of asthma, offering hope for improved outcomes for asthma sufferers. Dr. Samantha Walker of Asthma + Lung UK emphasises the importance of this research in addressing the unmet needs of asthma patients and underscores its potential implications for other inflammatory diseases.